ARTICLE | Clinical News

Trokendi XR topiramate regulatory update

June 27, 2016 7:00 AM UTC

Supernus said FDA asked the company to resubmit its proposed label for Trokendi XR topiramate to prevent migraines in a different format as part of the agency’s review of an sNDA. Supernus plans to re...